| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 10/05/2010 | US7807384 Drug screening; identifying a candidate agent that inhibits the binding of low density lipoprotein binding protein-2 (LBP-2) to an LBP-2 binding molecule |
| 10/05/2010 | US7807380 antibodies that specifically bind to native proBNP; method of correlating the level of native proBNP to the diagnosis of heart failure, a kit for detection of native proBNP and to a hybridoma cell line producing an antibody to native proBNP; biomarkers |
| 10/05/2010 | US7807371 Methods of selecting dopaminergic neuron proliferative progenitor cells using Lrp4/Corin markers |
| 10/05/2010 | US7807157 Monoclonal antibodies and use thereof |
| 10/05/2010 | US7807155 IL-17 antagonistic antibodies |
| 10/05/2010 | CA2578138C Production of tnfr-ig fusion protein |
| 10/05/2010 | CA2381438C Commercial production of chymosin in plants |
| 10/05/2010 | CA2086325C Ligand for cd28 receptor on b cells and methods |
| 09/30/2010 | WO2010111687A2 Methods and compositions for immunization against virus |
| 09/30/2010 | WO2010111018A1 Antibody drug conjugates (adc) that bind to 24p4c12 proteins |
| 09/30/2010 | WO2010110654A1 Method for preparation of heparin from mucosa |
| 09/30/2010 | WO2010110288A1 Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand |
| 09/30/2010 | WO2010109924A1 Lh-type bispecific antibody |
| 09/30/2010 | WO2010109920A1 Method for removing viruses in high-concentration monoclonal antibody solution |
| 09/30/2010 | WO2010085682A3 Stabilized fc polypeptides with reduced effector function and methods of use |
| 09/30/2010 | WO2010042562A3 Muc1* antibodies |
| 09/30/2010 | US20100251416 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production |
| 09/30/2010 | US20100249379 Protein expression from multiple nucleic acids |
| 09/30/2010 | US20100249376 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/30/2010 | US20100248971 Process for antibody production |
| 09/30/2010 | US20100248309 Thermostable alpha1-antitrypsin mutein with a disulfide bond and the method for preparing it |
| 09/30/2010 | US20100248308 Recombinant Microorganism and a Method for Producing Poly-Gamma-Glutamic Acid |
| 09/30/2010 | US20100248307 Peptide production method |
| 09/30/2010 | US20100248306 Expression System for the Antibiotic-Free Production of Polypeptides |
| 09/30/2010 | US20100248305 Polyamino acid synthetase and gene encoding the same |
| 09/30/2010 | US20100248304 Dual expression vector system and screening methods |
| 09/30/2010 | US20100248303 Method for recovering peptides/amino acids and oil/fat from one or more protein-containing raw materials, products produced by the method, and use of the products |
| 09/30/2010 | US20100248255 Novel peptides |
| 09/30/2010 | US20100248240 Gene and protein relating to hepatocellular carcinoma and methods of use thereof |
| 09/30/2010 | US20100247576 Nucleotide and amino acid sequences encoding an exported protein 1 derived from plasmodium vivax and uses thereof |
| 09/30/2010 | US20100247574 CHIMERIC NEWCASTLE DISEASE VIRUS VLPs |
| 09/30/2010 | US20100247571 Methods and compositions for immunization against virus |
| 09/30/2010 | US20100247560 Mutant botulinum neurotoxin serotype a polypeptide and uses thereof |
| 09/30/2010 | US20100247553 Goodpasture Antigen Binding Protein |
| 09/30/2010 | US20100247545 Antibodies to m-csf |
| 09/30/2010 | US20100247542 Truncated variant of the mammalian target for rapamycin (mtor) protein |
| 09/30/2010 | US20100247531 Anti-fgfr3 antibodies and methods using same |
| 09/30/2010 | US20100247526 Anti-NKG2A Antibodies and Uses Thereof |
| 09/30/2010 | US20100247523 Subtypes of humanized antibody against interleuken-6 receptor |
| 09/30/2010 | US20100247518 Modified proteins, designer toxins, and methods of making thereof |
| 09/30/2010 | US20100247509 Fusion Proteins |
| 09/30/2010 | US20100247442 Macaca fascicularis ST2L |
| 09/30/2010 | CA2756206A1 Methods and compositions for immunization against virus |
| 09/30/2010 | CA2754531A1 Antibody drug conjugates (adc) that bind to 24p4c12 proteins |
| 09/29/2010 | EP2233574A1 Mammalian cytokine: interleukin-B30 and related reagents |
| 09/29/2010 | EP2233571A1 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAS encoding the same |
| 09/29/2010 | EP2233567A1 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| 09/29/2010 | EP2233501A1 Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof |
| 09/29/2010 | EP2233498A1 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same |
| 09/29/2010 | EP2231856A2 In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris |
| 09/29/2010 | EP1929034B1 Cancerous disease modifying antibodies |
| 09/29/2010 | EP1888761B1 Recombinant n-glycosylated proteins from procaryotic cells |
| 09/29/2010 | EP1692159B1 Tgf-beta1 binding and supported peptides |
| 09/29/2010 | EP1476120B1 Treatment methods using anti-cd22 antibodies |
| 09/29/2010 | EP1450847B1 APO2 ligand/ TRAIL formulations and uses thereof |
| 09/29/2010 | EP1028972B1 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes |
| 09/29/2010 | EP0909328B1 Biological production of acetic acid from waste gases |
| 09/29/2010 | CN1908183B Enzymolytic hybrid peptide of native protein with endothelin antagonism |
| 09/29/2010 | CN101849003A Novel GPIIIa gene |
| 09/29/2010 | CN101848999A Anti-CD20 monoclonal antibodies |
| 09/29/2010 | CN101848998A Anti-EPHA2 antibody |
| 09/29/2010 | CN101845472A Method for preparing scale collagen antioxidant peptides by using no-feed supplement enzymolysis-membrane separation coupling technology |
| 09/29/2010 | CN101845457A Method for transfecting eukaryotic cell by using augmenter of liver regeneration (ALR) gene and application |
| 09/29/2010 | CN101845453A Optimized expression method of type 16 human papillomavirus L2E7 genes in colon bacillus |
| 09/29/2010 | CN101845444A Capsid protein gene and virus-like particles of shrimp infectious hypodermal and hematopoietic tissue necrosis |
| 09/29/2010 | CN101845440A Grouper adenylate cyclase activating polypeptide gene and expression system of mature peptide thereof, production method and application thereof |
| 09/29/2010 | CN101845098A Crystal of rat RANK/RANKL extracellular compound, preparation method and application thereof |
| 09/29/2010 | CN101845084A Recombination polypeptide serving as group A streptococcic tetravalent vaccine protective antigen |
| 09/29/2010 | CN101845080A Angiotensin converting enzyme inhibitory peptide and preparation method thereof |
| 09/29/2010 | CN101843896A Recombinant human interferon alpha 2b injection with high concentration and low filling quantity |
| 09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
| 09/29/2010 | CN101843259A Process for preparing natural herbicide by using corn protein powder |
| 09/29/2010 | CN101220096B Preparation and application of humanized anti-spasmotoxin monoclone antibody |
| 09/29/2010 | CN101152557B Preparation of aqueous extract and zymolyte of woodlousedry powder, and application of the same in medicine |
| 09/28/2010 | US7803925 Bacillus thuringiensis; conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds; controlling beetles; vectors, host cells |
| 09/28/2010 | US7803915 Ati-TAT88 polypeptide antibody; Anticarcinogenic agent; expression vector containign a nucleic acid operably linked to control sequences recognized by a host cell transformed with the vector |
| 09/28/2010 | US7803772 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity |
| 09/28/2010 | US7803637 Compositions and methods for treatment of neoplastic disease |
| 09/28/2010 | US7803616 culturing animal cells using a medium containing sericin to produce proteins of interest; useful for producing animal cell growth stimulating agent |
| 09/28/2010 | US7803614 isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevent and treatment; immunotherapy |
| 09/28/2010 | US7803602 Method for overexpression of zwitterionic polysaccharides |
| 09/28/2010 | US7803598 CGTase polypeptide with increased hydrolase activity; useful in preparing a food or a food product such as bakery products |
| 09/28/2010 | US7803595 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/28/2010 | US7803592 Substrate specificity for glucose is improved by substituting another amino acid residue for the amino acid residue at position 472 and/or 475; sensors, assay kits |
| 09/28/2010 | US7803591 Polynucleotide coding for a multimeric oxidoreductase complex having an alpha subunit, a gamma subunit and a cytochrome C subunit with specific amino acid sequences; used to manufacture of L-ascorbic acid |
| 09/28/2010 | US7803578 A gene encoding a protein having an improved nitrile hydratase activity, whereby heat resistance has been improved or substrate specificity has been changed; for efficient production of acrylamide |
| 09/28/2010 | US7803577 Polynucleotide encoding a tropoelastin polypeptide; expression products and hybrid molecules of the derivatives and variants |
| 09/28/2010 | US7803564 EGF-like nucleic acids and polypeptides and uses thereof |
| 09/28/2010 | US7803562 Method for screening human intestinal Npt2B modulatory agents |
| 09/28/2010 | US7803560 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist |
| 09/28/2010 | US7803553 Detecting the activation reactions of human transforming growth factor- beta 1, 2, and/or 3 in samples by staining or reacting the sample with an antibody against a latency-associated peptide fragment of human TGF- beta , that recognizes a protease cleavage site; diagnosing sclerotic diseases |
| 09/28/2010 | US7803524 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates |
| 09/28/2010 | US7803391 Bacillus thuringiensis; conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds; controlling beetles; vectors, host cells |
| 09/28/2010 | US7803387 With proteins of nisseria and purification of domains and gene expression of oligopeptides of ser, lys, ala, glu, gly and met |
| 09/28/2010 | US7803379 Tumour-specific animal proteins |
| 09/28/2010 | US7803377 Anti-DLL4 antibodies and methods using same |
| 09/28/2010 | US7803373 Chemokine panec-1 antibodies |
| 09/28/2010 | US7803371 Anti-VEGF antibody |
| 09/28/2010 | US7803361 Decreasing solid tumor size in a cancer patient by administering an interleukin-2 mutant with reduced vasopermeability activity compared to a wildtype form, and being Arg38Trp, wherein said wildtype form is human IL-2 mutant and the IL-2 mutant is not linked to an antibody. |
| 09/28/2010 | CA2422620C Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome p450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene |